NRX Pharmaceuticals (NRXP) Other Operating Expenses (2017 - 2026)

NRX Pharmaceuticals' (NRXP) quarterly Other Operating Expenses came in at $694000.0 in Q1 2026, up 54.22% on a QoQ basis from $450000.0 in Q4 2025.

NRX Pharmaceuticals (NRXP) Other Operating Expenses (2017 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has 8 years of Other Operating Expenses data on file, last reported at $694000.0 in Q1 2026.

On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $694000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 42133.33% increase from a year earlier, with the FY2025 full-year figure at $575000.0, up 11400.0% from the prior year.
Other Operating Expenses for Q1 2026 stood at $694000.0, up from $450000.0 in the prior quarter.
Over the last five years, Other Operating Expenses for NRXP reached as high as $694000.0 in Q1 2026 and fell as low as $1000.0 in Q4 2024.
Historically, Other Operating Expenses has averaged $254000.0 across 3 years, with a median of $123000.0 in 2025.
On a YoY basis, Other Operating Expenses climbed as much as 44900.0% in 2025 and fell as far as 6050.0% in 2025.
Year by year, Other Operating Expenses stood at $1000.0 in 2024, then soared by 44900.0% to $450000.0 in 2025, then jumped by 54.22% to $694000.0 in 2026.
Per Business Quant data, the three most recent Other Operating Expenses figures were $694000.0 in Q1 2026, $450000.0 in Q4 2025, and $123000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	NRX Pharmaceuticals	137.57 Mn	130.87 Mn	437,000.00

Download Data